Brinch L, Evensen S A, Albrechtsen D, Egeland T, Solheim B G, Rollag H, Naalsund A, Jacobsen A B
Medisinsk avdeling A, Rikshospitalet, Oslo.
Tidsskr Nor Laegeforen. 1991 Jan 30;111(3):311-5.
We present short and long-term results of allogeneic bone marrow transplantation after hyper-fractionated total body irradiation and high dose cyclophosphamide in ten patients treated for leukaemia during the period 1985-89. Three patients died from complications connected to the transplantation, while seven are living free from leukaemia 18 to 59 months after transplantation (mean 41 months). Two patients need treatment for chronic graft versus host disease. Allogeneic bone marrow transplantation is expensive and risky. Close cooperation between clinicians and laboratory specialists is essential. The treatment increases long term survival and probably cures certain patients with leukaemia. Some of these patients will need treatment for chronic graft versus host disease and other late sequelae.
我们展示了1985年至1989年期间接受超分割全身照射和高剂量环磷酰胺治疗的10例白血病患者进行异基因骨髓移植的短期和长期结果。3例患者死于与移植相关的并发症,7例在移植后18至59个月(平均41个月)无白血病存活。2例患者需要治疗慢性移植物抗宿主病。异基因骨髓移植费用高昂且风险大。临床医生和实验室专家之间密切合作至关重要。该治疗可提高长期生存率,并可能治愈某些白血病患者。其中一些患者需要治疗慢性移植物抗宿主病和其他晚期后遗症。